The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity–United States, 2000 to 2006 Donatus U. Ekwueme, MS, PhD, Gery P. Guy, MPH, PhD, Chunyu Li, MD, PhD, Sun Hee Rim, MPH, Pratibha Parelkar, MPH, Suephy C. Chen, MS, MD Journal of the American Academy of Dermatology Volume 65, Issue 5, Pages S133.e1-S133.e12 (November 2011) DOI: 10.1016/j.jaad.2011.04.036 Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Proportion of years of potential life lost (YPLL) because of melanoma relative to years of potential life lost because of all malignant cancers, by age at death and sex–United States, 2000 to 2006. Journal of the American Academy of Dermatology 2011 65, S133.e1-S133.e12DOI: (10.1016/j.jaad.2011.04.036) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Years of potential life lost and mortality ratios for 4 major cancer sites, melanoma, and all malignant cancers–United States, 2000 to 2006. Journal of the American Academy of Dermatology 2011 65, S133.e1-S133.e12DOI: (10.1016/j.jaad.2011.04.036) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions